![Maxine Gowen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maxine Gowen
Président chez
PASSAGE BIO, INC.
Fortune : 176 337 $ au 30/06/2026
Profil
Dr. Maxine Gowen is a Chairman at Passage Bio, Inc. and an Independent Director at Aclaris Therapeutics, Inc. She is on the Board of Directors at TamuroBio, Inc., Aclaris Therapeutics, Inc. and Conforma Therapeutics Corp.
Dr. Gowen was previously employed as an Independent Non-Executive Director by Merus NV, an Independent Director by Idera Pharmaceuticals, Inc., an Independent Director by Aceragen, Inc., an Independent Director by Akebia Therapeutics, Inc., an Independent Director by Human Genome Sciences, Inc., a SVP-External Drug Discovery Excellence Center by GlaxoSmithKline Plc, a President & Managing Partner by SR One Ltd., a VP-Drug Discovery & Musculoskeletal Diseases by GlaxoSmithKline Plc, a Head-Bone Cell Biology Group by University of Bath, and a Senior Vice President by Center of Excellence For External Drug Discovery.
She also served on the board at Panorama Medicine, Inc., Life Sciences Pennsylvania, Biotechnology Innovation Organization, Trevena, Inc., Azelon Pharmaceuticals, Inc., Morphotek, Inc. and Santarus, Inc. She received her undergraduate degree from the University of Bristol, an MBA from The Wharton School of the University of Pennsylvania, a doctorate degree from the University of Bath and a doctorate degree from The University of Sheffield.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 33 334 ( 0,02% ) | 176 337 $ | 30/06/2026 | |
PASSAGE BIO, INC. -.--% | 19/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Maxine Gowen
| Sociétés | Poste | Début |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 02/07/2019 |
| PASSAGE BIO, INC. | Président | 31/08/2021 |
TamuroBio, Inc.
 TamuroBio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Directeur/Membre du Conseil | 01/08/2019 |
Conforma Therapeutics Corp.
 Conforma Therapeutics Corp. BiotechnologyHealth Technology Designs and develops drugs for treatment of cancer | Directeur/Membre du Conseil | - |
Anciens postes connus de Maxine Gowen
| Sociétés | Poste | Fin |
|---|---|---|
| MERUS N.V. | Directeur/Membre du Conseil | 29/12/2025 |
| ACERAGEN, INC. | Directeur/Membre du Conseil | 15/08/2023 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Directeur/Membre du Conseil | 01/01/2022 |
| AKEBIA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 06/06/2021 |
| TREVENA, INC. | Fondateur | 01/05/2021 |
Formation de Maxine Gowen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
23
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 23 |
|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Morphotek, Inc.
 Morphotek, Inc. BiotechnologyHealth Technology Develops oncology therapies | Health Technology |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Engages in acquiring, developing and commercializing pharmaceutical products for the treatment of upper & lower gastrointestinal diseases and disorders | Health Technology |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures biopharmaceutical drugs for the treatment of osteoporosis | Commercial Services |
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. BiotechnologyHealth Technology Designs and develops drugs for treatment of cancer | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Bath
 University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biosciences industry | Commercial Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Trevena, Inc.
 Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Panorama Medicine, Inc.
 Panorama Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an drug discovery platform that integrates genomics, big data and computing to find drugs that can treat diseases caused by errors during RNA processing | Commercial Services |
Center of Excellence For External Drug Discovery | |
TamuroBio, Inc.
TamuroBio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Aceragen, Inc.
 Aceragen, Inc. BiotechnologyHealth Technology Discovers, develops, and commercializes therapeutics for oncology and rare diseases | Health Technology |
